Min Jiang
22Patents
8h-index
66Co-inventors
78Inventor score
Filing activity: Jun 5, 1996 → Apr 4, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8829007B2 | Inhibitors of influenza viruses replication | Chemistry; Metallurgy | 28 | Active |
| US9345708B2 | Inhibitors of influenza viruses replication | Chemistry; Metallurgy | 21 | Active |
| US9458153B2 | Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 19 | Active |
| US9518056B2 | Inhibitors of influenza viruses replication | Chemistry; Metallurgy | 16 | Active |
| US10093671B2 | 2-oxo-6,7-dihydrobenzo[a]quinolizine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 12 | Active |
| US9808459B2 | Inhibitors of influenza viruses replication | Chemistry; Metallurgy | 11 | Active |
| US5863543A | Camp factor of streptococcus uberis | Emerging Cross-Sectional Technologies | 8 | Expired |
| US9637485B2 | 6,7-dihydrobenzo[a]quinolizin-2-one derivatives for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 8 | Active |
| US10039762B2 | Inhibitors of influenza viruses replication | Chemistry; Metallurgy | 7 | Active |
| US9845322B2 | Tetrahydropyridopyrimidines and tetrahydropyridopyridines for the treatment and prophylaxis of hepatitis B virus infection | Human Necessities | 3 | Active |
| US10053461B2 | Tetracyclic 4-oxo-pyridine-3-carboxylic acid derivatives for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 3 | Active |
| US9949966B2 | Dihydroquinolizinones for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 2 | Active |
| US11104674B2 | Tetrahydropyridopyrimidines for the treatment of HBV infection | Chemistry; Metallurgy | 1 | Active |
| US11708344B2 | Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease | Chemistry; Metallurgy | 1 | Active |
| US6908619B1 | Camp factor of streptococcus uberis | Emerging Cross-Sectional Technologies | 0 | Expired |
| US9079892B2 | Method for preparing rivaroxaban intermediate | Emerging Cross-Sectional Technologies | 0 | Active |
| US11945167B1 | Three-degree-of-freedom convenient mobile powder recovery device and recovery method | Emerging Cross-Sectional Technologies | 0 | Active |
| US9458106B2 | Phenyl-pyridine/pyrazine amides for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US9562242B2 | Method for reusing water in fermented butanedioic acid separation process | Chemistry; Metallurgy | 0 | Active |
| US11225482B2 | Dihydropyrrolopyrimidines for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 0 | Active |
| US11447489B2 | Dihydropyrimidinylthiazole for the treatment and prophylaxis of hepatitis B virus infection | Chemistry; Metallurgy | 0 | Active |
| US10874673B2 | Inhibitors of influenza viruses replication | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.